glp 1 evolution A timeline of GLP- discovery and clinical development. Created in The Health and Healthcare Spending

Vallon V, Thomson SC

The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program

Insulin regimens can vary in complexity, and it is crucial to determine the patients willingness and capability to engage in self-management activities

Gupta et al., 2006

The best diabetes drug for weight loss for you depends on factors like: Whether or not you have type 2 diabetes or are a candidate for off-label use Your personal and family health history Your preference for oral medications versus injectable drugs Insurance coverage and out-of-pocket costs Your tolerance of the side effects Your weight loss and health goals If youre curious about diabetes drugs for weight loss, talk to your healthcare provider